Evidence map›Paper›PMID 37922316›Full record

ArticlePLoS medicine2023

Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England.

Sida Chen, Tom Marshall, Christopher Jackson, Jennifer Cooper, Francesca Crowe, Krish Nirantharakumar, Catherine L Saunders, Paul Kirk, Sylvia Richardson, Duncan Edwards and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Patterns of Multimorbidity among Older Adults with Colorectal Cancer Living in Puerto Rico.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sida ChenMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0009-0009-9409-9358
Tom MarshallInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-9277-5214
Christopher JacksonMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-6656-8913
Jennifer CooperInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-6566-4527
Francesca CroweInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-4026-1726
Krish NirantharakumarInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-6816-1279
Catherine L SaundersDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-3127-3218
Paul KirkMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
Sylvia RichardsonMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
Duncan EdwardsDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Simon GriffinDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2157-4797
Christopher YauNuffield Department for Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-7615-8523
Jessica K BarrettMRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1889-9803
University of Cambridge · GBUniversity of Birmingham · GBUniversity of Oxford · GB

Funding

Medical Research Council MC_UU_00002/11Medical Research Council MC_UU_00006/6
6 · The paper itself

Abstract

backgroundMultimorbidity, characterised by the coexistence of multiple chronic conditions in an individual, is a rising public health concern. While much of the existing research has focused on cross-sectional patterns of multimorbidity, there remains a need to better understand the longitudinal accumulation of diseases. This includes examining the associations between important sociodemographic characteristics and the rate of progression of chronic conditions. METHODS AND

findingsWe utilised electronic primary care records from 13.48 million participants in England, drawn from the Clinical Practice Research Datalink (CPRD Aurum), spanning from 2005 to 2020 with a median follow-up of 4.71 years (IQR: 1.78, 11.28). The study focused on 5 important chronic conditions: cardiovascular disease (CVD), type 2 diabetes (T2D), chronic kidney disease (CKD), heart failure (HF), and mental health (MH) conditions. Key sociodemographic characteristics considered include ethnicity, social and material deprivation, gender, and age. We employed a flexible spline-based parametric multistate model to investigate the associations between these sociodemographic characteristics and the rate of different disease transitions throughout multimorbidity development. Our findings reveal distinct association patterns across different disease transition types. Deprivation, gender, and age generally demonstrated stronger associations with disease diagnosis compared to ethnic group differences. Notably, the impact of these factors tended to attenuate with an increase in the number of preexisting conditions, especially for deprivation, gender, and age. For example, the hazard ratio (HR) (95% CI; p-value) for the association of deprivation with T2D diagnosis (comparing the most deprived quintile to the least deprived) is 1.76 ([1.74, 1.78]; p < 0.001) for those with no preexisting conditions and decreases to 0.95 ([0.75, 1.21]; p = 0.69) with 4 preexisting conditions. Furthermore, the impact of deprivation, gender, and age was typically more pronounced when transitioning from an MH condition. For instance, the HR (95% CI; p-value) for the association of deprivation with T2D diagnosis when transitioning from MH is 2.03 ([1.95, 2.12], p < 0.001), compared to transitions from CVD 1.50 ([1.43, 1.58], p < 0.001), CKD 1.37 ([1.30, 1.44], p < 0.001), and HF 1.55 ([1.34, 1.79], p < 0.001). A primary limitation of our study is that potential diagnostic inaccuracies in primary care records, such as underdiagnosis, overdiagnosis, or ascertainment bias of chronic conditions, could influence our results.

conclusionsOur results indicate that early phases of multimorbidity development could warrant increased attention. The potential importance of earlier detection and intervention of chronic conditions is underscored, particularly for MH conditions and higher-risk populations. These insights may have important implications for the management of multimorbidity.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Heart FailureRenal Insufficiency, ChronicChronic DiseaseCross-Sectional StudiesEnglandHumansMultimorbidityPrimary Health Care

Identifiers

PMID37922316
PMCPMC10655992
OpenAlexW4388285911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.